Abivax S.a.
Clinical trials sponsored by Abivax S.a., explained in plain language.
-
New daily pill aims to keep gut disease in remission for years
Disease control OngoingThis study is testing whether a daily pill called ABX464 (obefazimod) can safely keep ulcerative colitis under control long-term. It involves over 1,100 adults whose symptoms did not improve enough with standard treatments. The goal is to see if taking the pill daily for up to 4 …
Phase: PHASE3 • Sponsor: Abivax S.A. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Four-year gut disease treatment trial seeks lasting relief
Disease control OngoingThis study follows people with moderate to severe ulcerative colitis who are already taking the experimental drug ABX464. It aims to check the long-term safety and effectiveness of taking 25mg of ABX464 once daily for up to 54 months. The research will monitor patients for side e…
Phase: PHASE2 • Sponsor: Abivax S.A. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC